Inflammatory neuropathies: How far we’ve come
Medical Research Archives · 06.03.2024 · 12 (2)
DOI: 10.18103/mra.v12i2.4563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 06.03.2024. Verfasst von Kradolfer Letts Nicole Brigitte und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory polyneuropathies encompass a range of common and treatable conditions arising from an immune response—either humoral or cellular—targeting specific elements of the peripheral nervous system. These conditions may be acute, as in Guillain-Barré syndrome and its variants, or chronic, as observed in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, POEMS, vasculitis neuropathies, or nodal-paranodal disorders. Diagnosis predominantly hinges on clinical symptoms and electromyographic examinations, facilitating the prompt commencement of treatment. Addressing less common pathologies is crucial when conventional treatments prove ineffective, emphasizing the need for ongoing research in this dynamic field.
Zitieren
APA
Brigitte, K. L. N., & Tulio, B. (2024). Inflammatory neuropathies: How far we’ve come. Medical Research Archives, 12(2). https://doi.org/10.18103/mra.v12i2.4563
Vancouver
Brigitte KLN, Tulio B. Inflammatory neuropathies: How far we’ve come. Medical Research Archives. 2024;12(2). doi:10.18103/mra.v12i2.4563
BibTeX
@article{Brigitte2024,
author = {Brigitte, Kradolfer Letts Nicole and Tulio, Bertorini},
title = {Inflammatory neuropathies: How far we’ve come},
journal = {Medical Research Archives},
year = {2024},
volume = {12},
number = {2},
doi = {10.18103/mra.v12i2.4563}
}
EUVIMED